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Dear Editor, 
 
We read with interest the paper by Wang et al. and accompanying editorial showing 
that healthy murine airway epithelial cells (AECs) are potent inhibitors of dendritic 
cell (DC)-induced T cell activation.[1, 2] AECs infected with respiratory syncytial 
virus (RSV) lost this regulatory function allowing activation of T cell responses and 
airway inflammation.[1] These in vitro observations match with the high 
concentrations of pro-inflammatory mediators and cells found clinically in the 
bronchoalveolar lavage of infants with RSV bronchiolitis.[2]  
 
The paper by Wang et al. adds to a growing body of evidence that AECs are involved 
in maintaining airway immune homeostasis.[3] Mayer et al. previously demonstrated 
that primary murine and immortalised human AECs induce an anti-inflammatory 
microenvironment inhibiting DC maturation and reducing T cell proliferation through 
constitutive secretion of transforming growth factor-β. [3] Wang et al. comment that 
further studies in human primary AECs are required to validate the findings in a 
clinical setting. Smyth also highlights the importance of research to investigate the 
function of AECs in health [2].  
  
Primary AECs cultured from protocol bronchoscopic brushings taken from clinically 
stable lung allograft recipients free from chronic allograft dysfunction represent a 
useful model to study AEC function in a healthy, steady state, albeit alloimmune 
environment. In a recent paper we have shown that epithelial cell conditioned medium 
from stable lung allografts drives the production of macrophage-like cells from 
monocytes rather than DC.[4] It is unclear whether this effect only occurs in the 
airway of lung transplant recipients or if it reflects a general role for AECs in the 
homeostasis of DC populations in the lung. None the less, our findings provide 
complementary human evidence to the murine observations of Wang et al. and 
indicate that in a steady state AECs may be important in local immune homeostasis 
and promote an anti-inflammatory and pro-phagocytic airway milieu.             
 
An emerging hypothesis that encompasses these observations is therefore that in the 
healthy state AECs regulate local immune homeostasis in the epithelium and promote 
anti-inflammatory conditions in the airway. In response to epithelial damage, for 
example RSV infection, danger signals are released in to the microenvironment by 
AECs, which drive the production and maturation of professional antigen presenting 
DC, promoting T cell activation and airway inflammation.[5] 
 
To explore this hypothesis more fully we suggest that future studies should include 
primary human tissue in both health and disease and that this strategy can 
complement and extend animal studies.  
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